191 related articles for article (PubMed ID: 35348737)
21. DNA-PKc inhibition overcomes taxane resistance by promoting taxane-induced DNA damage in prostate cancer cells.
Chao OS; Goodman OB
Prostate; 2021 Oct; 81(14):1032-1048. PubMed ID: 34297853
[TBL] [Abstract][Full Text] [Related]
22. The role of cGAS-STING signalling in liver diseases.
Chen R; Du J; Zhu H; Ling Q
JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
[TBL] [Abstract][Full Text] [Related]
23. A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors.
Samuels M; Falkenius J; Bar-Ad V; Dunst J; van Triest B; Yachnin J; Rodriguez-Gutierrez A; Kuipers M; You X; Sarholz B; Locatelli G; Becker A; Troost EGC
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):743-756. PubMed ID: 37751793
[TBL] [Abstract][Full Text] [Related]
24. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy.
Chan Wah Hak CML; Rullan A; Patin EC; Pedersen M; Melcher AA; Harrington KJ
Front Oncol; 2022; 12():971959. PubMed ID: 36106115
[TBL] [Abstract][Full Text] [Related]
25. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
[TBL] [Abstract][Full Text] [Related]
26. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 deficiency sensitizes tumor cells to DNA-PK inhibition and enhances cGAS-STING activation.
Xue Z; Zheng S; Linghu D; Liu B; Yang Y; Chen MK; Huang H; Song J; Li H; Wang J; Hung MC; Zhong D; Sun L
Am J Cancer Res; 2022; 12(5):2363-2375. PubMed ID: 35693073
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control.
Nakamura K; Karmokar A; Farrington PM; James NH; Ramos-Montoya A; Bickerton SJ; Hughes GD; Illidge TM; Cadogan EB; Davies BR; Dovedi SJ; Valge-Archer V
Clin Cancer Res; 2021 Aug; 27(15):4353-4366. PubMed ID: 34011558
[TBL] [Abstract][Full Text] [Related]
29. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
[TBL] [Abstract][Full Text] [Related]
30. Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes With Radiation and PD-1 Blockade.
Zhuang Y; Wang Y; Liu C; Li S; Du S; Li G
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):894-905. PubMed ID: 36608830
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
Cui J; Chen Y; Wang HY; Wang RF
Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
[TBL] [Abstract][Full Text] [Related]
32. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer.
Yang SH; Kuo TC; Wu H; Guo JC; Hsu C; Hsu CH; Tien YW; Yeh KH; Cheng AL; Kuo SH
World J Gastroenterol; 2016 Aug; 22(32):7275-88. PubMed ID: 27621574
[TBL] [Abstract][Full Text] [Related]
33. ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways.
Feng X; Tubbs A; Zhang C; Tang M; Sridharan S; Wang C; Jiang D; Su D; Zhang H; Chen Z; Nie L; Xiong Y; Huang M; Nussenzweig A; Chen J
EMBO J; 2020 Jul; 39(14):e104036. PubMed ID: 32484965
[TBL] [Abstract][Full Text] [Related]
34. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage.
Cheon H; Holvey-Bates EG; McGrail DJ; Stark GR
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34799452
[TBL] [Abstract][Full Text] [Related]
36. Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.
Dylgjeri E; McNair C; Goodwin JF; Raymon HK; McCue PA; Shafi AA; Leiby BE; de Leeuw R; Kothari V; McCann JJ; Mandigo AC; Chand SN; Schiewer MJ; Brand LJ; Vasilevskaya I; Gordon N; Laufer TS; Gomella LG; Lallas CD; Trabulsi EJ; Feng FY; Filvaroff EH; Hege K; Rathkopf D; Knudsen KE
Clin Cancer Res; 2019 Sep; 25(18):5623-5637. PubMed ID: 31266833
[TBL] [Abstract][Full Text] [Related]
37. DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients.
Vasiyani H; Mane M; Rana K; Shinde A; Roy M; Singh J; Gohel D; Currim F; Srivastava R; Singh R
Apoptosis; 2022 Dec; 27(11-12):961-978. PubMed ID: 36018392
[TBL] [Abstract][Full Text] [Related]
38. POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling.
Oh G; Wang A; Wang L; Li J; Werba G; Weissinger D; Zhao E; Dhara S; Hernandez RE; Ackermann A; Porcella S; Kalfakakou D; Dolgalev I; Kawaler E; Golan T; Welling TH; Sfeir A; Simeone DM
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 36976649
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation.
Long X; Dai A; Huang T; Niu W; Liu L; Xu H; Yin T; Jiang T; Sun S; Lei P; Li C; Zhu X; Zhao J
ACS Nano; 2023 Jul; 17(13):12915-12932. PubMed ID: 37352467
[TBL] [Abstract][Full Text] [Related]
40. MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways.
Estrada-Bernal A; Chatterjee M; Haque SJ; Yang L; Morgan MA; Kotian S; Morrell D; Chakravarti A; Williams TM
Cell Cycle; 2015; 14(23):3713-24. PubMed ID: 26505547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
